NASDAQ

Allogene Therapeutics, Inc. (ALLO)

♥ 729 Thanks from members

Live price chart, market sentiment, and community perspectives for Allogene Therapeutics, Inc. (NASDAQ: ALLO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Cellectis SA (Parent), Alex SchuthLeadership: David Salmik (CEO)Leadership: Eric Schmidt (CFO)Holder: Pfizer Inc.Holder: Cellectis SAHolder: Baker Bros. AdvisorsALLO-501ALLO-715Allogeneic CAR T Therapies#ALLO#Allogene Therapeutics#CAR T#Biotech#NASDAQ